Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19911388 | 0.90 | FGFR1 (0.48) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19848217 | 0.79 | HTT (0.44) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19848700 | 0.79 | ALDH3A1 (0.42) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19911415 | 0.79 | MAPT (0.42) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19911373 | 0.79 | ALDH1A1 (0.64) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19911540 | 0.78 | ALDH1A1 (0.37) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19848341 | 0.76 | GABRP (0.38) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19848512 | 0.76 | USP2 (0.39) | ALDH1A1KMT2AMAPTGAASMN1; SMN2 | |
| SCHEMBL19848379 | 0.76 | HTT (0.46) | ALDH1A1MAPTGAASMN1; SMN2HTT | |
| SCHEMBL19911298 | 0.76 | ALDH3A1 (0.49) | ALDH1A1KMT2AGAAHTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062213-A1 | Nonaqueous Electrolyte and Nonaqueous Secondary Battery | BPTF, BRD4, KCNN2 | ALDH1A1 3497/4885KMT2A 458/4885MAPT 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.